COL18A1 and melanoma: Indeed, van der Schaft et al. demonstrated that using three angiogenic inhibitors (anginex, TNP-470 and endostatin) in human melanoma as compared to human endothelial cell lines inhibited angiogenesis in endothelial lines but did not inhibit vasculogenic mimicry in the melanoma lines.